Zimbabwe has rejected a substantial American healthcare agreement worth $367m (£272m) over five years because of the United States' insistence on sensitive biological samples.
This rejection became public after a government memo dated December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson later explained that the United States was demanding access to health data for research and commercial gain but refused to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued negotiations to secure a deal acceptable to both sides so the country's vital HIV programme can proceed.
Wider Background
This development comes after a comparable case in Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.
Based on statements, Sixteen nations in Africa have so far agreed to similar health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our people should a future pandemic arise."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were upending systems already set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This system is intended to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage further discussions with our American counterparts on how future co-operation could be structured in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that talks need to persist given that a large portion of the nation's Aids initiatives relied on external financing.
"In cases where technical issues exist, including those involving data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group said.
The situation underscores the continuing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.